Arkolith/Insider Trading/MLYS/Form 4

Congleton Jon

Chief Executive Officer, DirectorMineralys Therapeutics, Inc. (MLYS) · full profile →Form 4 · filed Apr 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.0M
Net Open-Market Flow
-$2.0M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2026Sell(S)19K$25.50$494K761K
Mar 31, 2026Sell(S)55K$26.54$1.5M706K
Mar 31, 2026Sell(S)453$27.05$12K705K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001644975-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML